본문 바로가기

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q1
저널
Annals of Laboratory Medicine41(2) · pp.207 · 2021
피인용
Web of Science 9Scopus 9KCI 0
FWCI (Scopus)
0
JCR IF
JCR 2020 3.464
ISSN
2234-3806

저자

  1. Seo, Ja Young제1저자Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
  2. Ahn, Jeong-YealDepartment of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
  3. Keam, BhumsukDivision of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
  4. Kim, MisoDivision of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
  5. Yoon, ShinkyoDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  6. Lee, Jae LyunDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  7. 박권오Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
  8. Park, Inkeun교신저자Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

초록

Background: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant cancer predisposition syndrome. HLRCC is characterized by the development of cutaneous leiomyomas, early-onset uterine leiomyomas, and HLRCC-associated renal cell cancer (RCC) and caused by germline fumarate hydratase (FH) deficiency. We investigated the genotypic and phenotypic characteristics of Korean patients with HLRCC. Methods: We performed direct sequencing analysis of FH in 13 patients with suspected HLRCC and their family members. A chromosomal microarray test was performed in female patients with negative sequencing results but highly suspected HLRCC. In addition, we analyzed the clinical characteristics and evaluated the genotype-phenotype correlations in Korean patients with HLRCC. Results: We identified six different pathogenic or likely pathogenic FH variants in six of the 13 patients (46.2%). The variants included two nonsense variants, two splicing variants, one frameshift variant, and one missense variant. Of the six variants, two (33.3%) were novel (c.132+1G>C, and c.243dup). RCC and early-onset uterine leiomyoma were frequently observed in families with HLRCC, while cutaneous leiomyoma was less common. No significant genotype-phenotype correlation was observed. Conclusions: We describe the genotypic and phenotypic spectrum in a small series of Korean patients with HLRCC. Our data reveal the unique characteristics of Korean patients with HLRCC and suggest a need for establishing an optimal diagnostic approach for them.

키워드

FHGenotypeHereditary leiomyomatosis and renal cell cancerKoreanNovel variantPhenotypeUTERINE LEIOMYOMASCARCINOMA SYNDROMEFH MUTATIONSFAMILIESSPECTRUMGENETUMORSHLRCC

식별자

Scopus EID
2-s2.0-85093484053
WoS UID
000598179900009
KCI
ART002686078